HIV Prevention Choices for Women in Uganda: Couples Study
Part of Infections clinical trials.
This research tests a tool that helps women and their partners make informed decisions about PrEP (a daily pill that prevents HIV). The study involves healthcare workers, patients, and leaders in Uganda to improve how women choose and use HIV prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Speak English or the main local language at your health facility
- Be able to give written permission to participate
- Participate in your assigned study activity (focus group, visit, interview, or survey)
- Not have any serious health or mental condition that would make participation unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help women at risk for HIV stay healthy while planning or having children. It provides prevention tools and support to reduce the chance of getting HIV.
This study tests ways to help young people in Uganda prevent HIV or stay healthy if they already have HIV. It offers free prevention pills or injections and care for those living with HIV.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study looks at how well a daily pill called PrEP can prevent HIV in pregnant women and their babies. It aims to make sure these women get the support they need to stay healthy.
This study offers different forms of HIV prevention medicine (PrEP) to young women ages 18–30 who are visiting clinics for reproductive health services like family planning or postnatal care. It aims to see which delivery method works best for you.
This study tests a support program to help young women stick with their HIV prevention medicine (PrEP). It aims to see if extra support helps them keep taking it regularly.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.